Modulation of the oestrogen receptor: A process with distinct susceptible steps

Human Reproduction Update

Volumn 6, Issue 3, 2000, Pages 207-211

  Cano, A ^a   Hermenegildo, C ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Mechanism of action; Oestrogen receptor modulators; Oestrogen receptor species; Tissue specificity

Indexed keywords

1,1,2 TRIPHENYLETHYLENE DERIVATIVE; ANTIESTROGEN; BENZOTHIOPHENE; CLOMIFENE; DNA; DROLOXIFENE; ESTRADIOL; ESTRADIOL RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NAFOXIDINE; PARTIAL AGONIST; RALOXIFENE; RECEPTOR SUBTYPE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TOREMIFENE; TRANSCRIPTION FACTOR;

DRUG ANTAGONISM; DRUG MECHANISM; DRUG RECEPTOR BINDING; HORMONE ACTION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA INTERACTION; SHORT SURVEY;

EID: 0034039060     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/6.3.207     Document Type: Short Survey

References (31)

1. Beato, M. and Klug, J. (1999) The superfamily of steroid hormone receptors. An update. Hum Reprod. Update, 6, 225-236.
2. Brzozowski, A.M., Pike, A.C.W., Dauter, Z. et al. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389, 753-758.
3. Cheskis, B.J., Karathanasis, S. and Lyttle, C.R. (1997) Estrogen receptor ligands modulate its interaction with DNA. J. Biol. Chem., 272, 11384-11391.
4. Coletta, A.A., Benson, J.R. and Baum, M. (1994) Alternative mechanisms of action of anti-oestrogens. Breast Cancer Res. Treat., 31, 5-9.
5. Danielian, P.S., White, R., Hoare, S.A. et al. (1993) Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol. Endocrinol., 7, 232-240.
6. Early Breast Cancer Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet, 351, 1451-1467.
7. Funder, J.W. (1993) Mineralcorticoids, glucocorticoids, receptors and response elements. Science, 259, 1132-1133.
8. Gallo, M.A. and Kaufman, D. (1997) Antaganostic and agonists effects of tamoxifen: significance in human cancer. Semin. Oncol., 24, S1-S76.
9. Goldstein, S., Siddhanti, S., Ciaccia, A. et al. (2000) A pharmacological review of selective oestrogen receptor modulators. Hum. Reprod. Update, 6, 212-224.
10. Halachmi, S., Marden, E., Martin, G. et al. (1994) Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science, 264, 1455-1458.
11. Hermenegildo, C. and Cano, A. (2000) Pure anti-oestrogens. Hum. Reprod. Update, 6, 237-243.
12. Horwitz, K.B., Jackson, T.A., Bain, D.L. et al. (1996) Nuclear receptor coactivators and compressors. Mol. Endocrinol., 10, 1167-1177.
13. Jackson, T.A., Richer, J.K., Bain, D.L. et al. (1997) The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors' N-CoR or SMRT. Mol. Endocrinol., 11, 693-705.
14. Jensen, E.V. and Jacobson, H.I. (1960) Fate of steroidal estrogens in target tissues. In Pincus, G. and Vollmer, E.P. (eds) Biological Activities of Steroids in Relation to Cancer. Academic Press, New York, USA, pp 161-174.
15. Kraus, W.L., McInerney, E.M. and Katzenellenbogen, B.S. (1995) Ligand-dependent, transcriptionally productive association of the amino-and carboxy-terminal regions of a steroid hormone nuclear receptor. Proc. Natl Acad. Sci. USA, 92, 12314-12318.
16. Kuiper, G.G., Enmark, E., Petto-Huikko, M. et al. (1996) Cloning of a novel estrogen receptor in rat prostate and ovary. Proc. Natl Acad. Sci. USA, 93, 5925-5930.
17. Kuiper, G.G., Carlsson, B., Grandien, K. et al. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology, 138, 863-870.
18. Lerner, L.J., Holthaus, J.F. and Thompson, C.R. (1958) A non-steroidal estrogen antagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl-ethanol. Endocrinology, 63, 295-318.
19. MacGregor, J.I. and Jordan, V.C. (1998) Basic guide to the mechanism of antiestrogen action. Pharmacol. Rev., 50, 151-196.
20. McDonnell, D.P., Clemm, D.L., Herman, T. et al. (1995a) Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol., 9, 659-669.
21. McDonnell, D.P., Dana, S.L., Hoener, P.A. et al. (1995b) Cellular mechanism which distinguish between hormone-and antihormone-activated estrogen receptor. Ann. N.Y. Acad. Sci., 761, 121-137.
22. Mosselman, S., Polman, J., Dijkema, R. (1996) Identification and characterization of a novel human estrogen receptor. FEBS Lett., 392, 49-53.
23. Onate, S.A., Tsai, S.Y., Tsai, M.J. et al. (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science, 270, 1354-1357.
24. Paech, K., Webb, P., Kuiper, G.G.J.M. et al. (1997) Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science, 277, 1508-1510.
25. Smith, C.L., Nawaz, Z. and O'Malley, B.W. (1997) Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol., 11, 657-666.
26. Spencer, C.P., Morris, E.P. and Rymer, J.M. (1999) Selective estrogen receptor modulators: women's panacea for the next millenium? Am. J. Obstet. Gynecol., 180, 763-770.
27. Tzukerman, M.T., Esty, A., Santiso-Mere, D. et al. (1994) Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol., 8, 21-30.
28. Umayahara, Y., Kawamori, R., Watada, H. et al. (1994) Estrogen regulation of the insulin-like growth factor-1 gene transcription involves an AP-1 enhancer. J. Biol. Chem., 269, 16433-16442.
29. Weiss, D.J. and Gurpide, E. (1988) Non-genomic effects of estrogens and antiestrogens. J. Steroid Biochem., 31, 671-676.
30. Williams, G.H. Steroid receptor specificity with reference to the estrogen receptor (1997) Osteoporosis Int., 1 (Suppl.), S35-S39.
31. Yang, N.N., Venugopalan, M., Hardikar, S. et al. (1996) Identification of an estrogen response element activated by metabolites of 17 β-estradiol and raloxifene. Science, 273, 1222-1225.